The trading week that was ended in a manner that many may have not anticipated. As we read this week’s Research Report, we can’t help but to recall the setup for the trading week that was found with some anxiety surrounding the December 15 tariffs. Investors had a choice to make at the beginning of the week; reduce market risk…
Geopolitical Risks Abate At Year-End: Sideways, Higher or Lower From Here?
A financial market resource for the every-day investor and trader.
-
Starbucks Q1 2018 Earnings Preview
Seth Golden, , Research Reports, 4
Starbucks is set to report its Q1 2018 results after the closing bell on January 25, 2018 and to...
-
Attempts to Renew The Uptrend Find Another Setback
Seth Golden, , Research Reports, 0
There was a great deal of concern for the manner in which the equity markets closed the week, 2...
-
VIX-Leveraged ETPs And The 5% Contango Rule
Seth Golden, , Research Reports, 0
On April 23, 2017 I informed readers, traders and investors alike as to the risks that lay before the...
-
J.C. Penney Share Price Has Followed Underperforming Same-Store-Sales Results
Seth Golden, , Research Reports, 0
Like many retail names, J.C. Penney (JCP) has reported a disappointing holiday sales period. With the retailer’s CEO previously...
-
Sensitive Markets Demand Resilient Investing Disciplines
Seth Golden, , Research Reports, 0
At the end of the previous trading week, the S&P 500 (SPX) was enjoying its fourth-straight up week (its...
-
Fundstrat: Choppy 8 Weeks Ahead, But…
Seth Golden, , Research Reports, 0
This coming week is important, given the Presidential debate on Tuesday evening (9pm ET). And as we look ahead,...
-
All Good At The Surface, But A Deeper Dive Identifies…
Seth Golden, , Research Reports, 0
Since the S&P 500’s 8-day win streak ended on November 8th, I think we can say that the market...
-
Growth Vs. Vaccine
Seth Golden, , Research Reports, 0
The J.P. Morgan View Growth versus virus now, vaccine versus virus later —an update on a conflict and a...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00